chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.84
Sex: F
Vaccine: DTAPHEPBIP, HIBV, MMR, PNC, VARCEL
Symptoms: Pyrexia
Clinical narrative: Fever that lasted 2 days straight. Even with children's Motrin and Tylenol, fever reached 104.8 at 4 am two days after shots were received. The fifth shot was Pneumococcal Conjugate and the manufacturer was WYETH-LEDERLE. The vaccine name was not listed on the drop menu.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Bacterial culture negative, Blood immunoglobulin G, Blood immunoglobulin M, Gram stain negative, Headache
Clinical narrative: June 24th - Reported to the ER with headache pain (10/10) and fever (max 102.8). Admitted to hospital for 6 days (discharged 30 June 2009). During his illness, the patient reported neck pain and photophobia. Will send follow-up after pt contacted and/or records obtained. 10/8/09 Received hospital medical records for 6/27-6/30/2009 FINAL DX: aseptic meningitis Records reveal paient experienced HA, neck pain, photophobia, left axillary & supraclavicular nodule, fever x 2 days.  Tx w/IV antibiotics & pain meds.  Multiple LPs done.  ID consult done.  Improved & d/c to home on pain meds for expected continued HA. ICD9 codes: 99709; 3218;E8796; 3051.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Neck pain, Pain, Photophobia, Polymerase chain reaction, Pyrexia
Clinical narrative: June 24th - Reported to the ER with headache pain (10/10) and fever (max 102.8). Admitted to hospital for 6 days (discharged 30 June 2009). During his illness, the patient reported neck pain and photophobia. Will send follow-up after pt contacted and/or records obtained. 10/8/09 Received hospital medical records for 6/27-6/30/2009 FINAL DX: aseptic meningitis Records reveal paient experienced HA, neck pain, photophobia, left axillary & supraclavicular nodule, fever x 2 days.  Tx w/IV antibiotics & pain meds.  Multiple LPs done.  ID consult done.  Improved & d/c to home on pain meds for expected continued HA. ICD9 codes: 99709; 3218;E8796; 3051.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Pain, Pyrexia
Clinical narrative: Redness and swelling up to 5" in place of injection. Pain, fever 100.4.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash, Viral rash
Clinical narrative: Rash on abdominal, face, legs, and arms X 2 days later probably viral reaction
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site mass, Injection site swelling, Injection site warmth
Clinical narrative: After 2nd HPV vaccine 5 days later pt experienced swelling (lump) and hotness at injection site.  Recc cold compresses
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Blood creatine phosphokinase MB, Blood creatine phosphokinase normal, Body temperature increased, C-reactive protein increased, Chest X-ray normal
Clinical narrative: A 28-year-old male patient received vaccination with smallpox vaccine on an unknown date. The manufacturer and lot number of the vaccine were not reported in the literature reference nor was the date of vaccination. Fourteen days post-vaccination the patient presented to the emergency room with a four day history of chest pain described as positional, pleuritic, nonexertional and progressive, malaise, myalgias, fever and shaking chills. The symptoms became progressively worse over the following three days and the patient was admitted to the hospital with a suspected diagnosis of myopericarditis. On initial evaluation the patient was febrile with a fever of 39.2 degrees Celsius and had otherwise normal vital signs, cardiovascular examination and lung auscultation. The skin exam revealed acne scattered pustules on the scalp and upper back which the patient reported started a few days after vaccination. Initial laboratory data was remarkable for Troponin I of 0.16 mg/dL with normal creatine kinase (CK) and CK-MB. Electrocardiogram demonstrated diffuse concave ST elevation that was consistent with generalized epicardial injury. The patient was treated with nonsteroidal anti-inflammatory drugs and the pain did not worsen. A second set of Troponin I eight hours after admission was 0.63 mg/dL. An echocardiogram demonstrated normal ventricular function and no pericardial effusion. Chest x-ray was normal. Sedimentation rate was 30 mm/hr and C-reactive protein was 8.6 mg/dL. The patient was discharged after 24 hours and one week later was asymptomatic. A repeat electrocardiogram was remarkable for resolution of the diffuse ST elevation seen on admission and new T-wave inversions that were consistent with resolving pericarditis. No other information was provided. List of documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Chest pain, Chills, Echocardiogram normal, Ejection fraction normal, Electrocardiogram ST segment elevation
Clinical narrative: A 28-year-old male patient received vaccination with smallpox vaccine on an unknown date. The manufacturer and lot number of the vaccine were not reported in the literature reference nor was the date of vaccination. Fourteen days post-vaccination the patient presented to the emergency room with a four day history of chest pain described as positional, pleuritic, nonexertional and progressive, malaise, myalgias, fever and shaking chills. The symptoms became progressively worse over the following three days and the patient was admitted to the hospital with a suspected diagnosis of myopericarditis. On initial evaluation the patient was febrile with a fever of 39.2 degrees Celsius and had otherwise normal vital signs, cardiovascular examination and lung auscultation. The skin exam revealed acne scattered pustules on the scalp and upper back which the patient reported started a few days after vaccination. Initial laboratory data was remarkable for Troponin I of 0.16 mg/dL with normal creatine kinase (CK) and CK-MB. Electrocardiogram demonstrated diffuse concave ST elevation that was consistent with generalized epicardial injury. The patient was treated with nonsteroidal anti-inflammatory drugs and the pain did not worsen. A second set of Troponin I eight hours after admission was 0.63 mg/dL. An echocardiogram demonstrated normal ventricular function and no pericardial effusion. Chest x-ray was normal. Sedimentation rate was 30 mm/hr and C-reactive protein was 8.6 mg/dL. The patient was discharged after 24 hours and one week later was asymptomatic. A repeat electrocardiogram was remarkable for resolution of the diffuse ST elevation seen on admission and new T-wave inversions that were consistent with resolving pericarditis. No other information was provided. List of documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Electrocardiogram abnormal, Malaise, Myalgia, Myopericarditis, Pleuritic pain
Clinical narrative: A 28-year-old male patient received vaccination with smallpox vaccine on an unknown date. The manufacturer and lot number of the vaccine were not reported in the literature reference nor was the date of vaccination. Fourteen days post-vaccination the patient presented to the emergency room with a four day history of chest pain described as positional, pleuritic, nonexertional and progressive, malaise, myalgias, fever and shaking chills. The symptoms became progressively worse over the following three days and the patient was admitted to the hospital with a suspected diagnosis of myopericarditis. On initial evaluation the patient was febrile with a fever of 39.2 degrees Celsius and had otherwise normal vital signs, cardiovascular examination and lung auscultation. The skin exam revealed acne scattered pustules on the scalp and upper back which the patient reported started a few days after vaccination. Initial laboratory data was remarkable for Troponin I of 0.16 mg/dL with normal creatine kinase (CK) and CK-MB. Electrocardiogram demonstrated diffuse concave ST elevation that was consistent with generalized epicardial injury. The patient was treated with nonsteroidal anti-inflammatory drugs and the pain did not worsen. A second set of Troponin I eight hours after admission was 0.63 mg/dL. An echocardiogram demonstrated normal ventricular function and no pericardial effusion. Chest x-ray was normal. Sedimentation rate was 30 mm/hr and C-reactive protein was 8.6 mg/dL. The patient was discharged after 24 hours and one week later was asymptomatic. A repeat electrocardiogram was remarkable for resolution of the diffuse ST elevation seen on admission and new T-wave inversions that were consistent with resolving pericarditis. No other information was provided. List of documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Pyrexia, Rash, Rash pustular, Red blood cell sedimentation rate increased, Troponin I increased
Clinical narrative: A 28-year-old male patient received vaccination with smallpox vaccine on an unknown date. The manufacturer and lot number of the vaccine were not reported in the literature reference nor was the date of vaccination. Fourteen days post-vaccination the patient presented to the emergency room with a four day history of chest pain described as positional, pleuritic, nonexertional and progressive, malaise, myalgias, fever and shaking chills. The symptoms became progressively worse over the following three days and the patient was admitted to the hospital with a suspected diagnosis of myopericarditis. On initial evaluation the patient was febrile with a fever of 39.2 degrees Celsius and had otherwise normal vital signs, cardiovascular examination and lung auscultation. The skin exam revealed acne scattered pustules on the scalp and upper back which the patient reported started a few days after vaccination. Initial laboratory data was remarkable for Troponin I of 0.16 mg/dL with normal creatine kinase (CK) and CK-MB. Electrocardiogram demonstrated diffuse concave ST elevation that was consistent with generalized epicardial injury. The patient was treated with nonsteroidal anti-inflammatory drugs and the pain did not worsen. A second set of Troponin I eight hours after admission was 0.63 mg/dL. An echocardiogram demonstrated normal ventricular function and no pericardial effusion. Chest x-ray was normal. Sedimentation rate was 30 mm/hr and C-reactive protein was 8.6 mg/dL. The patient was discharged after 24 hours and one week later was asymptomatic. A repeat electrocardiogram was remarkable for resolution of the diffuse ST elevation seen on admission and new T-wave inversions that were consistent with resolving pericarditis. No other information was provided. List of documents held by sender: None.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Abnormal behaviour, Gait disturbance, Somnolence, Speech disorder
Clinical narrative: Patient felt clinic was reported by mom to be "acting drunk" unsteady gait, saying inappropriate things. Was then sleepy. Episode lasted about 4 hours. Spontaneously resolved on own. Patient observed at home. Did not seek medical attention.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Erythema, Oedema peripheral, Tenderness
Clinical narrative: 7/11 - arm (upper) was reported as red and swollen. Rx BENADRYL and warm compresses. 7/12 - redness spread to wrist but swelling decreased and tenderness. 7/13 - seen in office. Redness from deltoid - wrist. Minimal swelling. Rx - PREDNISONE 1 pl BID x 4d.
Age: 13.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Erythema, Mass, Pain in extremity, Swelling
Clinical narrative: Pain 24 hours after shot - swelling redness lump under tissue 1.5cm. Cont x 4 days came in - Tx ice to area (5 minutes intervals! and BENADRYL 25mg Q6hrs and TYLENOL for pain.
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: 4-5 inch raised, red, hot area around injection site.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Abasia, Facial palsy, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Initial report was received 14 July 2009 from a consumer, who is also the patient. A 36-year-old female patient with no medical history and no concurrent illness, had received a left deltoid intramuscular injection of ADACEL, lot number C3057AA on 25 March 2009 and six weeks later (also reported as 06 May 2009), she developed numbness and tingling in her tongue, hands and feet. Three days later, she was unable to walk. She began having facial paralysis and difficulty speaking and went to the emergency room. She was admitted and diagnosed with GBS (Guillain-Barre Syndrome) and spent the next eight weeks in the hospital and rehabilitation. The patient had no history of adverse events following prior vaccinations and she had not received any other vaccines during the four weeks prior to receipt of ADACEL. Concomitant medications included birth control pills. At the time of the report, the patient had been improving. No further information was provided at the time of the report. Documents held by sender: None
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Paraesthesia, Paraesthesia oral, Speech disorder
Clinical narrative: Initial report was received 14 July 2009 from a consumer, who is also the patient. A 36-year-old female patient with no medical history and no concurrent illness, had received a left deltoid intramuscular injection of ADACEL, lot number C3057AA on 25 March 2009 and six weeks later (also reported as 06 May 2009), she developed numbness and tingling in her tongue, hands and feet. Three days later, she was unable to walk. She began having facial paralysis and difficulty speaking and went to the emergency room. She was admitted and diagnosed with GBS (Guillain-Barre Syndrome) and spent the next eight weeks in the hospital and rehabilitation. The patient had no history of adverse events following prior vaccinations and she had not received any other vaccines during the four weeks prior to receipt of ADACEL. Concomitant medications included birth control pills. At the time of the report, the patient had been improving. No further information was provided at the time of the report. Documents held by sender: None
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site infection, Injection site swelling, Injection site warmth
Clinical narrative: 7-13-09 child received 4 immunizations at Dr office. 7-15-09 site of MMR was red, hot and raised, no fever, no malaise, child acting normally. Went to see physician assistant at the clinic, placed on KEFLEX in case of cellulitis prevention. Pt saw PA 7/16/09 area of infection much better per the PA.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion spontaneous, Drug exposure during pregnancy, Pregnancy test positive, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received for the pregnancy registry for GARDASIL from a master of science in nursing concerning a 26 year old female with no pertinent medical history and allergy to erythromycin who on 24-MAR-2008 was vaccinated with the first 0.5mL dose of GARDASIL IM (Lot No. 655604/0052X) and on 19-MAY-2008 was vaccinated with the second 0.5mL dose of GARDASIL IM (Lot No. 660389/1968U). Concomitant therapy included MOTRIN and vitamins (unspecified). The patient received her first two doses of GARDASIL and is now pregnant. The patient sought medical attention, seen by the practice. The last menstrual period was on 01-JUL-2008. On an unspecified date, was performed a urine pregnancy test and a serum pregnancy test resulting positive. Estimated date of delivery approximately on 07-APR-2009. The patient has not experienced any known symptoms. Follow up information has been received from a case manager in the office, concerning a 26 year old female who on 17-FEB-2009 "lost" the baby. However, the mother is fine. The office hasn't really followed her and doesn't have much more information. Upon internal review: the patient "lost" her baby, was considered as other important medical event. No further information is available.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Left upper arm below injection site is red\swollen\hard\hot. Approximately 11cm in length and 9 1/4 cm across. Given BENADRYL and tx with antibiotic prophylaxis.
Age: 10.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Left deltoid at injection site red\swollen\itchy area approximately 1" across and 4" down. No rash or anaphylactic reaction noted. Instructed to give BENADRYL 25 mg every 4-6 hrs, office visit if worsens.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Computerised tomogram normal, Convulsion, Tuberculin test negative
Clinical narrative: Information has been received from a consumer concerning her 19 year old daughter with no medical history and drug allergies, who in approximately "September 2008" was vaccinated with her 1st dose of GARDASIL. The 2nd dose was unspecified. On 29-MAY-2009, the patient received the 3rd dose of GARDASIL, 0.5ml, IM. Subsequently, the patient had a seizure when she was sleeping on 25-JUN-2009. She was sent to ER but was not admitted. There was no concomitant medication. Lab diagnostics studies included EEG, CAT scan, and MRI. The patient had seen a neurologist about the seizure. The patient had recovered from seizure on 25-JUN-2009. Follow-up information had been received through a phone call, a nurse concerning that the patient was vaccinated with her 1st dose of GARDASIL (Lot#660391/0063X) on 16-JUL-2008, concomitantly received ADACEL (lot# C2994AA), HAVRIX (lot# AHAVB235BA), and tuberculin purified protein derivative (PPD) (LOT#C2907BA), results negative. The 2nd dose of GARDASIL (lot# 659184/0843X) was administered on 10-OCT-2008, and concomitant therapy included FLUMIST (lot#50545P). On 28-MAY-2009, the patient received the 3rd dose of GARDASIL (lot# 662300/0100Y), 0.5ml, IM. On 25-JUN-2009, the patient had a seizure and was taken to hospital but not admitted. The patient's CT scan was negative and EEG results were pending. The patient mother felt that the patient's seizure and was taken to hospital but not admitted. The patient's CT scan was negative and EEG results were pending. The patient mother felt that the patient's seizures were linked to GARDASIL vaccinations. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.  7/21/09 ER records received DOS 6/25/09. Assessment: New Onset Seizure. Parent witnessed patient's seizure in bed. Lost consciousness, unresponsive, confusion. Patient presents with trace swelling of tongue, tachycardia. To have MRI with Gandolinium.  9/11/09 Medical records received DOS 7/16/08 to 7/14/09. Generalized seizure. Tongue bitting. Went to ER. Neurology consult. ENT consult for otitis externa. Fever.  9/18/09 Neurology consult received DOS 7/8/09. Assessment: New onset one-time generalized seizure. Witnessed gneralized tonic-clonic seizure while asleep. Recent bilateral ear infections.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: Right upper arm swollen, warm to touch, pinkish color.
Age: 29.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Pediatric dose of Hep B given to adult on 7/6/09, followed by adult dose given on 7/9/09. No adverse s/s.
Age: 46.0
Sex: F
Vaccine: TD
Symptoms: Arthralgia, Limb discomfort, Pain
Clinical narrative: Pain. Pressure both lower legs (calf) and behind knees: helped by resting (in recliner). Makes worse: walking.
Age: 25.0
Sex: M
Vaccine: DT
Symptoms: Wrong drug administered
Clinical narrative: Tetanus booster given on: DECAVAC - 1-26-07 - correct Booster as last Booster was 1997. DECAVAC - 1-8-08. DECAVAC - 1-9-09. No adverse symptoms as result of.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site papule, Injection site pustule
Clinical narrative: Local Rxn. 2 Red papules L thigh, surrounding redness, one with pustule no streaks.
Age: 56.0
Sex: M
Vaccine: PPV
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Pyrexia
Clinical narrative: High fever, chills, diarrhea, weakness, dizziness. Supportive care, Tylenol.
Age: 55.0
Sex: F
Vaccine: HEPAB
Symptoms: Anxiety, Dizziness, Dyspnoea, Fatigue, Visual impairment
Clinical narrative: Patient described dizziness, vision disturbance, shortness of breath and severe fatigue. Onset of symptoms about 3 hrs after vaccination. Pt. stated severe anxiety R/T shots/needles @ time of vaccination. Pt. referred to physician, unknown if treated.
Age: 42.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pt c/o pain and swelling to R arm several hours after admin. PNEUMOVAX. Pt returned to clinic 7/16/09 for eval. Pt still had redness to injection site and had travelled down to arm and elbow.
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Nausea, Product quality issue, Pruritus, Skin exfoliation
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of itchy hands and feet in a female subject of unspecified age who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medications included Hydrochlorothiazide. On 5 June 2009, the subject received 2nd dose of ENGERIX B (1 ml, unknown, left arm). On 6 June 2009, one day after vaccination with ENGERIX B, the subject experienced itchy hands and feet and skin peeling. On 02 July 2009, 27 days after vaccination with ENGERIX B, the subject experienced vertigo, dizziness and nausea. The healthcare professional reported that this subject was given the ENGERIX vaccination on 05 June 2009 and the next day 06 June 2009, she started experiencing intense itching of the hands and feet that was followed by peeling of the hands. The itching resolved on 10 June 2009 but the peeling of the skin on the hands continued at the time of the report. On 02 July 2009, the subject also experienced vertigo (dizziness and nausea) that required her to obtain medical attention at the emergency room (ER). The physician in the ER prescribed ANTIVERT and FENERGAN to treat the symptoms of vertigo. The healthcare professional considered the events were disabling and clinically significant (or requiring intervention). The subject was treated with ANTIVERT and FENERGAN. At the time of reporting the itching resolved, peeling of skin was unresolved, vertigo was improved, nausea and dizziness were unknown. Follow-up information was received on 14 July 2009, via healthcare professional who reported the subject received ENGERIX B in the right arm on 05 June 2009. The subject experienced itchy hands and feet, skin peeling, vertigo and pharmaceutical product complaint after vaccination with ENGERIX B. The subject was hospitalized. The subject was treated with ANTIVERT 25 mg tablets and FENERGAN (as needed) for vertigo and a moisturizing cream for skin peeling. The skin peeling had improved and vertigo resolved on 03 July 2009. The healthcare professional considered the itchy hands and feet and skin peeling probably related to vaccination with ENGERIX B and the event of vertigo was possibly related to vaccination with ENGERIX B.
Sex: F
Vaccine: HEP
Symptoms: Vertigo
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of itchy hands and feet in a female subject of unspecified age who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medications included Hydrochlorothiazide. On 5 June 2009, the subject received 2nd dose of ENGERIX B (1 ml, unknown, left arm). On 6 June 2009, one day after vaccination with ENGERIX B, the subject experienced itchy hands and feet and skin peeling. On 02 July 2009, 27 days after vaccination with ENGERIX B, the subject experienced vertigo, dizziness and nausea. The healthcare professional reported that this subject was given the ENGERIX vaccination on 05 June 2009 and the next day 06 June 2009, she started experiencing intense itching of the hands and feet that was followed by peeling of the hands. The itching resolved on 10 June 2009 but the peeling of the skin on the hands continued at the time of the report. On 02 July 2009, the subject also experienced vertigo (dizziness and nausea) that required her to obtain medical attention at the emergency room (ER). The physician in the ER prescribed ANTIVERT and FENERGAN to treat the symptoms of vertigo. The healthcare professional considered the events were disabling and clinically significant (or requiring intervention). The subject was treated with ANTIVERT and FENERGAN. At the time of reporting the itching resolved, peeling of skin was unresolved, vertigo was improved, nausea and dizziness were unknown. Follow-up information was received on 14 July 2009, via healthcare professional who reported the subject received ENGERIX B in the right arm on 05 June 2009. The subject experienced itchy hands and feet, skin peeling, vertigo and pharmaceutical product complaint after vaccination with ENGERIX B. The subject was hospitalized. The subject was treated with ANTIVERT 25 mg tablets and FENERGAN (as needed) for vertigo and a moisturizing cream for skin peeling. The skin peeling had improved and vertigo resolved on 03 July 2009. The healthcare professional considered the itchy hands and feet and skin peeling probably related to vaccination with ENGERIX B and the event of vertigo was possibly related to vaccination with ENGERIX B.
Age: 28.0
Sex: M
Vaccine: MMR, MNQ, TDAP, VARCEL
Symptoms: Body temperature increased, Chills, Fatigue, Orthostatic intolerance, Tremor
Clinical narrative: Pt recieved four shots right arm (Meningococcal, TDaP, MMR, and Varicella). Had Hyperimmune response with shaking, chills, and temp of 100.6.  Pt refused IV fluids.  Brought back to the clinic and found to have a temp of 103.1 and positive orthostasis.  Given 1 gm of IM Rocephin, medrol dose pack, prn tylenol, po bactrim, cool compresses, quarters for 24 hours.  Pt stated he feel better, but still has mild fatigue and chills, but temp improved to 99.3.
Age: 28.0
Sex: M
Vaccine: MMR, MNQ, TDAP, VARCEL
Symptoms: Urine analysis
Clinical narrative: Pt recieved four shots right arm (Meningococcal, TDaP, MMR, and Varicella). Had Hyperimmune response with shaking, chills, and temp of 100.6.  Pt refused IV fluids.  Brought back to the clinic and found to have a temp of 103.1 and positive orthostasis.  Given 1 gm of IM Rocephin, medrol dose pack, prn tylenol, po bactrim, cool compresses, quarters for 24 hours.  Pt stated he feel better, but still has mild fatigue and chills, but temp improved to 99.3.
Age: 14.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Dyspnoea, Hypoaesthesia, Nausea, Paraesthesia, Pyrexia
Clinical narrative: 6-24-09 Fever 103 and nausea  6-27-09 Tingling and numbness of all extremities and shortness of breath
Age: 47.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain upper, Arthralgia, Headache, Nausea, Pyrexia
Clinical narrative: severe joint pain, headache, nausea, stomach pains, low grade fever. Treated with appropriate fever lowering agent
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Had swelling and redness at the injection site. Required topical treatment and Tylenol.
Age: 18.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Blood pressure decreased, Convulsion, Feeling hot, Lethargy, Malaise
Clinical narrative: PATIENT CAME TO HEALTH DEPARTMENT FOR COLLEGE IMMUNIZATIONS. NERVOUS ABOUT SHOTS. DETERMINED NEEDED Tdap(FOR COLLEGE ENTRY), MENACTRA, AND GARDASIL (LAST 2 FOR COMPLETE IMMUNIZATIONS SERIES). EXPLAINED SIDE EFFECTS. TDAP GIVEN IN LEFT DELTOID AND GARDASIL GIVEN IMMEDIATELY AFTER IN LEFT UPPER ARM. PATIENT SAID THAT SHE DID NOT FEEL WELL, BECAME PALE AND FAINTED. LOWERED TO FLOOR FROM CHAIR. PALE, AND HAD WHAT APPEARED TO BE A SEIZURE. WITHIN SECONDS WAS TALKING BUT COMPLAINED OF BEING WARM. B/P 72/59 PULSE 84/MIN,NEVER STOPPED BREATHING. 911 CALLED AND RESPONDED B/P INCREASED AND PATIENT SITTING IN CHAIR AND SAYS FEELS BETTER. SHE SIGNED THAT SHE DIDN'T WANT TO GO TO ER AND THEY LEFT. WITHIN ABOUT 4 MINUTES SHE FAINTED AGAIN. LOWERED TO FLOOR AND PATIENT WAS TALKING BUT LETHARGIC. B/P WAS 112/ FIRST RESPONDERS RETURNED AND SITTING IN CHAIR B/P 108/ DRINKING SOME JUICE AND TALKING WITH 1ST RESPONDERS. AFTER APPROX 5 MINUTES WHILE FIRST RESPONDERS WERE STILL HERE SHE FAINTED AGAIN AND APPEARED TO HAVE A SEIZURE. FIRST RESPONDERS LOWERED HER TO FLOOR AND WITHIN SECONDS AGAIN SHE WAS RESPONDING AND TALKING. DECISION TO TRANSPORT TO ER.  7/24/09 ER records received DOS 7/17/09. Final Diagnosis: Vasovagal syncope. Patient reports receiving 2 shots today and passing out before receiving the 3rd. Total of 3 episodes syncope. Anxious. Presents for evaluation of syncope.  ICD-9 Codes: 780.2
Age: 18.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Pallor, Syncope
Clinical narrative: PATIENT CAME TO HEALTH DEPARTMENT FOR COLLEGE IMMUNIZATIONS. NERVOUS ABOUT SHOTS. DETERMINED NEEDED Tdap(FOR COLLEGE ENTRY), MENACTRA, AND GARDASIL (LAST 2 FOR COMPLETE IMMUNIZATIONS SERIES). EXPLAINED SIDE EFFECTS. TDAP GIVEN IN LEFT DELTOID AND GARDASIL GIVEN IMMEDIATELY AFTER IN LEFT UPPER ARM. PATIENT SAID THAT SHE DID NOT FEEL WELL, BECAME PALE AND FAINTED. LOWERED TO FLOOR FROM CHAIR. PALE, AND HAD WHAT APPEARED TO BE A SEIZURE. WITHIN SECONDS WAS TALKING BUT COMPLAINED OF BEING WARM. B/P 72/59 PULSE 84/MIN,NEVER STOPPED BREATHING. 911 CALLED AND RESPONDED B/P INCREASED AND PATIENT SITTING IN CHAIR AND SAYS FEELS BETTER. SHE SIGNED THAT SHE DIDN'T WANT TO GO TO ER AND THEY LEFT. WITHIN ABOUT 4 MINUTES SHE FAINTED AGAIN. LOWERED TO FLOOR AND PATIENT WAS TALKING BUT LETHARGIC. B/P WAS 112/ FIRST RESPONDERS RETURNED AND SITTING IN CHAIR B/P 108/ DRINKING SOME JUICE AND TALKING WITH 1ST RESPONDERS. AFTER APPROX 5 MINUTES WHILE FIRST RESPONDERS WERE STILL HERE SHE FAINTED AGAIN AND APPEARED TO HAVE A SEIZURE. FIRST RESPONDERS LOWERED HER TO FLOOR AND WITHIN SECONDS AGAIN SHE WAS RESPONDING AND TALKING. DECISION TO TRANSPORT TO ER.  7/24/09 ER records received DOS 7/17/09. Final Diagnosis: Vasovagal syncope. Patient reports receiving 2 shots today and passing out before receiving the 3rd. Total of 3 episodes syncope. Anxious. Presents for evaluation of syncope.  ICD-9 Codes: 780.2
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Local reaction
Clinical narrative: Local reaction, red, swollen, hurts, no temp. Shots on Tuesday, reaction gone on Friday.  Did not see doctor.  Used cold compress at sight.
Age: 11.0
Sex: M
Vaccine: TDAP, VARCEL
Symptoms: Erythema, Local reaction, Pain, Swelling
Clinical narrative: Local reaction, red, swollen, hurts, no temp.  Shots on Tuesday reaction gone on Friday.  Did not see a doctor.  Used cold compress at injection site.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Blister, Erythema, Induration, Skin warm, Swelling
Clinical narrative: The patient received a Dtap in the left arm, and about 36-48 hours later, had onset of induration, swelling, warmth, and erythema, resembling cellulitis.  The area was 4 x 5 inches.  There was also a 1.5 inch round area of vesicle/blisters inside the red area, but NOT immediately around the injection site.  She was started on Bactrim for presumed cellulitis.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Injection site pain, Musculoskeletal pain, Nausea, No reaction on previous exposure to drug
Clinical narrative: Calls to say is declining 3rd Gardasil  Still having shoulder pain from 2nd inj.   Day of 1st inj and after no sx.  2nd inj: day of inj headache ,nausea, sore arm.  Severe pain con't at injection site for 1 wk.   If rolled on arm would wake her up do to the pain.  If leaned on Rt elbow would get referred pain in rt shoulder and at inj site.  Pain intermittently con't in right shoulder and inj site.  Feels some of pain is in shoulder Joint. This pain con't thru today though is intermittent.  Pt did not seek Tx of any kind and this is the first time she is reporting this to a medical provider.  Pt wants adverse reaction form completed.   Form found on WIR Web site.  Pt understands information will be sent to CDC and FDA where information on adverse Rx form  Her identity will be kept confidential. Pt to call back if Sx do not go away. Pt. expresses understanding will follow above plan.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Pain in extremity
Clinical narrative: Calls to say is declining 3rd Gardasil  Still having shoulder pain from 2nd inj.   Day of 1st inj and after no sx.  2nd inj: day of inj headache ,nausea, sore arm.  Severe pain con't at injection site for 1 wk.   If rolled on arm would wake her up do to the pain.  If leaned on Rt elbow would get referred pain in rt shoulder and at inj site.  Pain intermittently con't in right shoulder and inj site.  Feels some of pain is in shoulder Joint. This pain con't thru today though is intermittent.  Pt did not seek Tx of any kind and this is the first time she is reporting this to a medical provider.  Pt wants adverse reaction form completed.   Form found on WIR Web site.  Pt understands information will be sent to CDC and FDA where information on adverse Rx form  Her identity will be kept confidential. Pt to call back if Sx do not go away. Pt. expresses understanding will follow above plan.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Red, warm, raised area at vaccine site for one week. 2.5cm in length. Denies fever, pain, or other symptoms. Treatment given, tylenol and benedryl.
Age: 24.0
Sex: F
Vaccine: HEP, HPV4, TDAP, VARCEL
Symptoms: Blister, Rash vesicular
Clinical narrative: SEVERAL HOURS AFTER RECEIVING THE VARICELLA VACCINE, THE PATIENT EXPERIENCED BLISTERS ON HER BODY. THE BLISTERS RESEMBLED VARICELLA INFECTION.
Age: 1.83
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Blood test, Joint swelling, Pyrexia, Rash
Clinical narrative: Painfull swelling of joints(knees and elbows).  High fever, rash all over back and abdomen.  Motrin and Tylenol given for the pain and inflamation.    Every couple of weeks there is a recurrence of the swelling in the right knee inpeticular
Age: 38.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Ocular hyperaemia, Swelling face
Clinical narrative: Less than 24 hours after vaccinations were administered patient had redness around both eyes with facial swelling.
Age: 1.17
Sex: M
Vaccine: DTAPIPVHIB, MMR, VARCEL
Symptoms: Injection site rash, Pyrexia
Clinical narrative: Fever began on 7/16/2009, 8 days after MMR vaccine. Fever up to 102.5 on 7/17/2009. Eating and drinking well, playing and responsive to parents.Temp down to 98.4 after Tylenol. Father states there is a small rash just at the injection site.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pyrexia
Clinical narrative: Localized erythema, warmth to touch, tenderness at injection site. Pt. reported fever developed the day after vaccine was administered.  Pt. was seen at clinic for treatment on 07/17/09 with temp. of 98.7 F.  She was prescrived Augmentin, Zyrtec and instructed to apply warm compresses.
Age: 21.0
Sex: F
Vaccine: DTAP
Symptoms: Asthenia, Fatigue, Headache, Neck pain, Pain in jaw
Clinical narrative: PT'S MOM CALLED TODAY TO REPORT THAT PT HAD RXN TO TDAP VACCINE RECIEVED YESTERDAY. REPORTS HEADACHE, NECK/JAW ACHE, WEAKNESS/FAITGUE. DENIES ANY REDNESS OR SWELLING AT INJECTION SITE. DENIES SOB OR DIFFICULTY BREATHING. PT'S MOM REPORTS THAT PT "BLEACHED TEETH OVERNIGHT" AND HAS ALSO BEEN "TRYING TO FIGHT OFF SINUS INFECTION". RECOMMENDED OTC MEDS (TYLENOL, MOTRIN, BENEDRYL) FOR S/S. INSTRUCTED TO F/U WITH PRIMARY MD IF S/S PERSIST AND TO GO TO ER IF S/S WORSEN. AGREED WITH POC. WILL F/U WITH PT ON MONDAY.
Age: 17.0
Sex: F
Vaccine: HEP, HEPA, HPV4, IPV, MNQ, TDAP
Symptoms: Facial palsy, Paraesthesia
Clinical narrative: Client had vaccines 7/16/2009.  Reports that at 11:30 this am (7/17/09) she started with lower facial tingling and family member says that when the client spoke her lips and lower side of face appeared to be pushed to the right side. Denies any weakness but smile does appear to be lopsided when client returned to clinic today at 3:30 pm. Denies any additional symptoms. Referred to primary doctor and left center at 3:45 pm to see doctor. (Family member made appt. while in office at center 7/17/09 ) Doctor contacted family for follow-up. Stated that family took pt to doctor on 7/17 and was diagnosed with Bells Palsy.
Age: 12.0
Sex: F
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: 4in by 4in redness surrounding vaccine site. Itchy and a little sore. Started about 24hrs after vaccine.
Age: 16.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site pain, Myalgia, Pain in extremity, Serology normal
Clinical narrative: Pt. developed acute arm pain at the site of injection & the following day spread to both arms & legs; diffuse muscle pain throughout developed over 1 week period. Pt had Rheumatology consult to & Normal serology confirm.  7/21/09 Medical records received DOS 5/1/09 to 6/08/09. Assessment: Muscle pains with chronic pain and fatigue. Reaction to vaccination with Varicella or Menactra. Patient presents with left arm pain. Myalgia and arthralgia. Pain in muscles, aching in knees, ankles, wrists, and elbows. Ultracet made her very confused. Trigger point tenderness. Pain management clinic dx: pain amplification syndrome.  9/1/09 Consultant Pain Clinic records received DOS 6/5/09 to 7/10/09. Assessment: Pain Disorder Associated with Both Psychological Factors and a General Medical Condition. Pain and redness at injection site. Pain later extended to entire left arm. In the following weeks pain extended to left leg, right leg, right arm. Pain is throbbing and constantly moves between extremities. Back pain, tense muscles, multiple joint soreness. Stress at school. Acute distress, crying. Exhausted. Shortness of breath, dizziness, paresthesia 4 extremities. Acupuncture. Massage. Poor sleep.  9/10/09 Rheumatology consult records received DOS 5/20/09. Assessment: Juvenile Fibromyalgia. Patient c/o injection pain, redness and numbness along left arm. Pain spread throughout body. Numbness resolved in 2 days. 1 day of severe headaches. Energy decreased. Difficulty falling asleep. Dizziness. Distress, crying.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Shingles vaccine resulted in a case of shingles.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Injection site erythema, Injection site warmth, Malaise, Rash pruritic
Clinical narrative: Woke am after injection with chills, malaise, warm, red urea at site. Woke next am with pruritic rash on legs.
Age: 4.0
Sex: M
Vaccine: DTAP, HEP, IPV, MMR
Symptoms: Injection site oedema
Clinical narrative: 7 mm brawny edema area on right upper arm.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site nodule, Injection site swelling
Clinical narrative: 7-16-09 pm noticed swelling adn redness at inj. site.  In clinic 7-17-09 upper arm red with hard knot and swelling of right arm at inj. site.Area of 2 1/2 by 3cm induration with 5cm of redness at MMR site.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discolouration, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Approx. 24 hours after vaccination, injection area began swelling, ultimately to the size of a large orange; erythema, pruritis, tenderness, very hard and lumpy.  Remained that way for four days.  Approximately one week later still itching minimally and area is slightly discolored.  Pharmacist wanted to report the Lot #: 1555X
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Approx. 24 hours after vaccination, injection area began swelling, ultimately to the size of a large orange; erythema, pruritis, tenderness, very hard and lumpy.  Remained that way for four days.  Approximately one week later still itching minimally and area is slightly discolored.  Pharmacist wanted to report the Lot #: 1555X
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Biopsy, Biopsy bone marrow, Chemotherapy, Computerised tomogram, Deafness
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Echocardiogram, Lymphadenopathy, Nasopharyngitis, Non-Hodgkin's lymphoma, Positron emission tomogram abnormal
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Surgery
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chemotherapy, Computerised tomogram abnormal, Deafness unilateral, Diffuse large B-cell lymphoma, Haemorrhage
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Lymphadenopathy, Mass, Non-Hodgkin's lymphoma, Pain
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Aspiration biopsy, Aspiration bone marrow, Chemotherapy, Computerised tomogram abnormal, Deafness unilateral
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Diffuse large B-cell lymphoma, Echocardiogram, Laryngoscopy, Lymphadenopathy, Lymphoma
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Neoplasm, Non-Hodgkin's lymphoma, Positron emission tomogram abnormal, Surgery
Clinical narrative: Patient received Zostavax vaccine for shingles on 2-2-2009. Patient lost hearing in right ear, developed swollen neck glands and growth in nasopharynx. Patient diagnosed with non-Hodgkins lymphoma 04/29/09.  Patient now receiving chemotherapy.  7/24/09 Medical records received DOS 2/20/09. Zostavax administered.
Age: 12.0
Sex: F
Vaccine: HPVX
Symptoms: Asthenia, Dizziness, Dysphonia, Pallor, Pyrexia
Clinical narrative: Moderate fever, hoarseness, paleness, weakness, and dizziness.  started 9:30 pm on July 14, 2009, and ended 1:30 am July 17, 2009. treatment:ibprophen, tylenal, and acedominophen.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Measles antibody positive, Measles post vaccine, Rash generalised, Rubella antibody test
Clinical narrative: 13 mth old male received MMR #1, Varicella #1 on 6/15/09. Presented with c/o rash all over body, seen at ER, Measles IgM, IgG titers sent from ER, 7/10/09 (+u), followed up at PCP's office 2 days later, rash subsides, of suspected Measles repeat IgM, IgG titers sent on 7/15/09. (+) IgG titers.
Age: 13.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: 6"X4" area on back of left arm. Red, swollen, and warm.
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Feeling hot, Induration, Oedema peripheral
Clinical narrative: (L) side Deltoid swollen noticed 7.16.09 unsure fever, felt hot mom gave 1 dose of TYLENOL induration 8 cm x 7 cm Red & Hard as per mom the induration was bigger notice today.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, PNC
Symptoms: Injection site urticaria
Clinical narrative: Urticana @ vaccine sites 0 anaphylaxis, 0 emesis, 0 resp distress, supportive care only.
Age: 16.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema, Injection site warmth, Skin warm
Clinical narrative: L deltoid injection, 2 hours later L arm red and worn from site down to L hand.
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site haemorrhage, Injection site swelling
Clinical narrative: DPT and IPV given in lower mid Lt thigh where bled after injection VARIVAX then swelled and became red / Lt posterior arm was in injected 3x / keep pulling away - reddened.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Anorexia, Crying
Clinical narrative: Persistent crying with loss of appetite since administration of vaccines (PENTACEL, Hep B, PREVNAR & ROTATEQ) on 7/14/09.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Abnormal faeces, Haematochezia, Mucous stools
Clinical narrative: Developed stools with bloody mucus, foul odor 5 days after ROTATEQ given - ? anal fissure (not clearly seen). No elevated stool frequency irritability or other signs of illness.
Age: 17.0
Sex: F
Vaccine: HEP, HPV4, IPV, MMR, TD, VARCEL
Symptoms: Drug exposure during pregnancy
Clinical narrative: Client given 6 shots on 7-14-09.  Received call today stating she is 6 months pregnant.  Will see physician on 7-21-09.  Repeated requests to the report originating physicians and/or clinics to provide the missing information on the original VAERS submittals were unsuccessful.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Muscle spasms, Physical examination normal, Pregnancy test positive
Clinical narrative: Information has been received from a consumer for the Pregnancy Registry for GARDASIL concerning her 18 year old daughter who on 24-MAR-2008 was vaccinated with her first dose of GARDASIL (lot# not reported) and was pregnant.  The patient's estimated LMP was 09-FEB-2008.  The pregnancy was confirmed with a pregnancy test.  The patient sought unspecified medical attention and the physician's information was not available.  Follow-up information has been received from a Certified Medical Assistant, who reported that their office did not have any records of the patient receiving GARDASIL injections.  In follow-up, the Certified Medical Assistant indicated that on 04-NOV-2008 the patient delivered a normal, healthy male baby weighing 8 pounds, 11 ounces via vaginal delivery.  The patient had no complications in her pregnancy, just some "muscle spasms".  There was no indication that there were any problems with the baby either.  The mother returned for her postpartum exam on 19-DEC-2008 and had a full normal exam and had an intrauterine device (IUD) inserted for contraception.  The Certified Medical Assistant contacted during telephone follow-up could not supply the following information:  lot number, healthcare provider name and contact information.  No further information is available at this time.  No further information is available at this time.